Atara Biotherapeutics, Inc. - Common Stock (ATRA)
9.3400
+0.0400 (0.43%)
Atara Biotherapeutics is a biotechnology company that focuses on developing transformative therapies for patients with serious medical conditions, particularly in the areas of cancer and autoimmune diseases
The company leverages its proprietary platform to create innovative T-cell immunotherapy treatments, which harness the power of the immune system to target and attack disease. Atara's commitment to scientific research and collaboration is aimed at advancing the field of cellular therapies, and it is dedicated to improving the lives of patients by addressing unmet medical needs through its cutting-edge therapeutic solutions.
Frequently Asked Questions
Is Atara Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Atara Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Atara Biotherapeutics, Inc. - Common Stock trade on?
Atara Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Atara Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Atara Biotherapeutics, Inc. - Common Stock is ATRA on the Nasdaq Stock Market
What is the current price of Atara Biotherapeutics, Inc. - Common Stock?
The current price of Atara Biotherapeutics, Inc. - Common Stock is 9.340
When was Atara Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Atara Biotherapeutics, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Atara Biotherapeutics, Inc. - Common Stock?
The market capitalization of Atara Biotherapeutics, Inc. - Common Stock is 944.29M
How many shares of Atara Biotherapeutics, Inc. - Common Stock are outstanding?
Atara Biotherapeutics, Inc. - Common Stock has 101.10M shares outstanding.